Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
Critical Care Medicine|March 11, 2003
Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemiaSteven M Opal, John E Palardy, Nicolas Parejo, et al.
Critical Care Medicine|April 24, 2008
Sepsis: time to reconsider the conceptJean Carlet, Jonathan Cohen, Thierry Calandra, et al.
Inflammation|March 26, 2010
Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in ratsClaire Boland, Valérie Collet, Emmanuelle Laterre, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2020
In-hospital management of persons with haemophilia and COVID-19: Practical guidanceCedric Hermans, Catherine Lambert, Amaury Sogorb, et al.
Mbio|June 25, 2015
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor BlockersDavid S Fedson, Jeffrey R Jacobson, Ole Martin Rordam, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|October 7, 2014
Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodiesThomas T DeLeon, Heath H Chung, Steven M Opal, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2003
Defibrination and systemic bleeding caused by an imported African snakebitePhilippe Hantson, David Verhelst, Xavier Wittebole, et al.
Shock (Augusta, Ga.)|September 21, 2017
Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort StudyNicolas Moreau, Xavier Wittebole, Yvan Fleury, et al.
Journal of Critical Care|April 5, 2022
Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trialNicolas De Schryver, Nicolas Serck, Stéphane Eeckhoudt, et al.
Critical Care (London, England)|September 13, 2002
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]Dale Rublee, Steven M Opal, Wolfgang Schramm, et al.
Pageof 23